Active Trials

• A5128: Consent for Use of Stored Patient Specimens for Future Testing

  Study Location: Baltimore

  Eligibility: Genders Eligible for Study:   Both Accepts Healthy Volunteers:   Yes Sampling Method:   Non-Probability Sample...

  Enrollment: Open

  Read More

• A5300B/I2003B/PHOENIX, Protecting Households On Exposure to Newly Diagnosed...

  Study Location: India

  Eligibility: Men and women age greater than or equal to 18 year

  Enrollment: Open

  Read More

• A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing...

  Study Location: Baltimore

  Eligibility: Men and women > 18 years old who have HIV-associated neurocognitive disorder (HAND) as defined by the Frascati...

  Enrollment: Open

  Read More

• A5384: A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of...

  Study Location: India

  Eligibility: Target Participant Age 15 years and older Definite, probable, or possible TBM diagnosis from testing performed as part of...

  Enrollment: Open

  Read More

• ACTIV-2/A5401: Adaptive Platform Treatment for Outpatients with COVID-19...

  Study Location: BaltimoreIndia

  Eligibility: Adults

  Enrollment: Open

  Read More

• Identification of Biomarkers That Can Predict Progression from Latent...

  Study Location: India

  Eligibility: Adult, Pediatric, Household contacts

  Enrollment: Open

  Read More

• IMPAACT 2034 - Phase I Study of the Pharmacokinetics, Safety, and...

  Study Location: India

  Eligibility: Ages Eligible for Study: up to 17 Years (Child ) Sexes Eligible for Study: Female Accepts Healthy Volunteers: No

  Enrollment: Open

  Read More

• Impact of Tuberculosis Infection on HIV-1 Antibody Response (NWCS501)

  Study Location: BaltimoreIndia

  Eligibility: Adults, adolescents

  Enrollment: Open

  Read More

• P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the...

  Study Location: India

  Eligibility: Ages Eligible for Study:   up to 18 Years   (Child, Adult) Sexes Eligible for Study:   All Accepts Healthy...

  Enrollment: Open

  Read More

• P2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the...

  Study Location: India

  Eligibility: HIV-infected and HIV-uninfected infants, children, and adolescents less than 18 years of age with confirmed or probable MDR-TB.

  Enrollment: Open

  Read More

• P2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis...

  Study Location: BaltimoreIndia

  Eligibility: Preg/postpartum women. Infants

  Enrollment: Open

  Read More

• The Pharmacokinetics, Safety and Acceptability of New Child-Friendly...

  Study Location: India

  Eligibility: Pediatrics

  Enrollment: Open

  Read More